TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
Abstract Background Pancreatic cancer is a highly aggressive malignancy with limited treatment options and a poor prognosis. Trophoblast cell surface antigen 2 (TROP2), a cell surface antigen overexpressed in the tumors of more than half of pancreatic cancer patients, has been identified as a potent...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2023-11-01
|
| Серія: | Journal of Nanobiotechnology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12951-023-02183-9 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|